Almaarefa University
The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.

المخرجات

Research outputs

Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.

ReviewOpen (repository)202613citation· Semantic Scholar

Anticancer Molecular Mechanisms of Curcuminoids: An Updated Review of Clinical Trials

Food Science & Nutrition · vol. 14 (2) · e71452-e71452

(turmeric), and have received much attention due to their pleiotropic anticancer properties. Recent evidence suggests that curcumin and analogs prevent the activation of a variety of signaling pathways, including the MAPK, PI3K/Akt, and NF-kB pathways, resulting in the induction of apoptosis, prevention of proliferation, and suppression. In addition to these processes, curcumin has been shown to enhance the efficacy of the conventional anti-cancer modalities such as radiation and chemotherapy. By suppressing the expression of matrix metalloproteinases (MMPs), which are enzymes that break down the extracellular matrix and promote cancer cell invasion and metastasis, curcumin also demonstrates anti-metastatic qualities. Inflammation and the advancement of cancer are linked to the NF-κB signaling pathways, which are also suppressed by curcuminoids. Along with these processes, curcumin has demonstrated the ability to improve the effectiveness of traditional cancer treatments, including radiation and chemotherapy. It increases the sensitivity of cancer cells to various therapies, which enhances the therapeutic results. However, curcumin's low bioavailability limits its therapeutic use. Its anticancer potency may be increased, and this restriction may be overcome due to recent developments in drug delivery technologies, such as curcumin-loaded nanoparticles. Since they can target several different molecular pathways and improve the effectiveness of current treatments, curcuminoids are a promising family of chemicals for the prevention and treatment of cancer.

curcuminoidscurcuminanticancer mechanismMAPK signaling
ReviewOpen access20269citation· Semantic Scholar

Recent advances in immunotherapy for gliomas: overcoming barriers and advancing precision strategies

Frontiers in Immunology · vol. 16 · 1690464-1690464

Gliomas, and particularly glioblastoma (GBM), remain among the most lethal primary brain tumors, with outcomes constrained by extensive intra tumor heterogeneity, a profoundly immunosuppressive tumor microenvironment (TME), and the restrictive nature of the blood-brain barrier (BBB). Although immunotherapies, including immune checkpoint inhibitors, chimeric antigen receptor (CAR) T and NK cells, and oncolytic virotherapy, have redefined treatment paradigms in other malignancies, their efficacy in gliomas has been modest, limited by low tumor mutational burden, antigenic plasticity, metabolic suppression, and therapy-associated immunosuppression. Recent advances in multi-antigen targeting, metabolic reprogramming, and innovative delivery strategies have enhanced preclinical efficacy, while the integration of emerging biomarkers such as ADAMTSL4, ACSS3, and radiomics-derived immune signatures offers opportunities for precision patient stratification. Converging developments in real-time molecular monitoring, spatial immunoprofiling, and rationally designed combination regimens hold the potential to recalibrate the glioma immune landscape, paving the way toward clinically impactful and durable immunotherapeutic responses.

glioma immunotherapyglioblastomaimmunosuppressive tumor microenvironmentblood-brain barrier
ArticleOpen access20269citation· Semantic Scholar

pH-responsive hyaluronic acid- co -poly(acrylic acid) hydrogel scaffolds for modified release of mesalamine; characterization and biosafety evaluation

RSC Advances · vol. 16 (6) · 5561-5577

The current study focuses on the development of pH-sensitive hydrogels for the controlled release of mesalamine at a specific pH. A free radical polymerization technique was used, and the formulated hydrogels were characterized by Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis, scanning electron microscopy, swelling and drug release studies. FTIR confirmed the successful formation of a polymeric network with efficient incorporation of the drug. TGA revealed that the hydrogel demonstrated significantly improved thermal stability compared to the unmodified polymer, with SEM images showing a rough surface with a notable porous structure. Swelling and drug release behaviors were assessed at 37 °C in buffer solutions simulating gastric (pH 1.2) and intestinal (pH 7.4) conditions. The results demonstrated significantly higher swelling ratios and drug release rates at pH 7.4, indicating pH-responsive characteristics of the formulation, favoring enhanced drug release in the intestinal conditions. Increasing the concentrations of hyaluronic acid and acrylic acid led to enhanced porosity, improved swelling behavior, increased drug loading capacity, faster release rates, and a higher gel fraction, while simultaneously reducing the sol fraction. These observations suggested that the developed pH-sensitive hydrogel holds considerable potential as an effective carrier for pH-responsive, site-specific drug delivery systems. This study highlights the significant advancements in the design of hydrogels with tailored properties for controlled drug release, offering new opportunities for precision medicine.

pH-responsive hydrogelshyaluronic acidpoly(acrylic acid)5-aminosalicylic acid
ArticleOpen access20267citation· Semantic Scholar

Prevalence of polypharmacy and drug interactions in geriatric patients: A cross-sectional study from India

PLoS ONE · vol. 21 (2) · e0341183-e0341183

BACKGROUND: Polypharmacy and potential drug-drug interactions (pDDIs) are major challenges in the management of elderly patients with multiple comorbidities, often leading to adverse drug events and increased healthcare burden. AIM: This study aimed to determine the prevalence and patterns of polypharmacy and pDDIs among elderly patients attending Yenepoya Medical College and Hospital, Mangalore, India. METHODS: A cross-sectional study was conducted from January to June 2023 among 310 elderly patients (aged ≥60 years) selected through simple random sampling from both in-patient and out-patient departments. Polypharmacy was defined as the concurrent use of ≥5 medications, and excessive polypharmacy as ≥9 medications. Drug interaction screening was performed using UpToDate and Medscape interaction checker tools. Statistical analyses included descriptive statistics, t-tests, chi-square tests, and regression analysis, with significance set at p < 0.05. RESULTS: The prevalence of polypharmacy was slightly higher in females (53.84%) than males (51.94%), with the highest rates observed in the 70-79 age group (48.88%). Most patients experienced moderate (50%) drug interactions. A significant gender difference was observed in the number of drugs prescribed at treatment (p = 0.0032), but not at discharge. Regression analysis identified gender (p = 0.018) and inpatient status (p < 0.001) as significant predictors of polypharmacy, while age was not (p = 0.719). CONCLUSION: This study reveals a high prevalence of polypharmacy among elderly patients attending Yenepoya Medical College and Hospital. Polypharmacy was found to be more prevalent among female patients, older age groups, and in inpatient wards. The distribution of drug interactions revealed a pervasive nature across various degrees, with moderate interactions being the most common. Future research should use larger samples, and diverse populations to better understand polypharmacy, drug interactions, and outcomes.

polypharmacydrug-drug interactionselderly patientsolder adults
ReviewOpen (repository)20266citation· Semantic Scholar

Perioperative outcomes and safety of Uniportal Robotic-Assisted Thoracic Surgery (U-RATS) for anatomic lung resection: a systematic review and meta-analysis

Journal of Robotic Surgery · vol. 20 (1)

Uniportal robotic-assisted thoracic surgery (U-RATS) represents a recent evolution in minimally invasive lung resection, combining the single-incision philosophy with robotic technology. However, its perioperative safety and outcomes have not been clearly defined across published studies. A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines and a registered protocol. PubMed, Web of Science, and the Cochrane Library were searched for studies reporting perioperative outcomes of U-RATS for anatomic lung resection in adults. Primary outcomes included conversion rate, morbidity, and mortality. Secondary outcomes were operative time, estimated blood loss, length of hospital stay, and lymph node yield. Random-effects models were applied to pool estimates. Sixteen studies encompassing 579 patients were included. The pooled conversion rate was 1.34% (95% CI: 0.42–4.15%), with no observed heterogeneity. The pooled postoperative morbidity rate was 5.99% (95% CI: 4.46–7.91%), and the pooled mortality rate was 0.21% (95% CI: 0.07–0.64%). The pooled mean operative time was 171.3 min, the estimated blood loss was 51.9 mL, and the postoperative length of stay was 4.9 days. Across 11 studies, the pooled lymph node yield was 16.6 nodes (95% CI: 14.0–19.2; I² = 89.8%). Current evidence suggests that U-RATS is a safe and feasible approach for anatomic lung resection, with low conversion and complication rates and acceptable perioperative outcomes comparable to established minimally invasive techniques.

anatomical lung resectionperioperative outcomesconversion ratepostoperative morbidity
ArticleOpen access20266citation· Semantic Scholar

Personalized multi-agent reinforcement learning framework for adaptive chronic disease therapy management

Scientific Reports · vol. 16 (1)

Long-term, flexible therapy strategies are needed for chronic diseases like cardiovascular ailments, diabetes, and chronic kidney disease and they have to deal with patient heterogeneity, changing physiological states and privacy constraints. This research suggests a framework for privacy-preserving and personalized artificial intelligence that combines Federated Learning (FL), a Res-HyperTransformerNet deep prediction model, Personalized Multi-Agent Reinforcement Learning (PMARL) and Explainable Artificial Intelligence (XAI) for adaptive chronic disease management. The framework is structured with two main aims: (i) to create an accurate and privacy-aware predictive model for chronic disease risk using diverse data sources, and (ii) to permit adaptive, individual therapy optimization through multi-agent reinforcement learning. Federated learning is utilized to conduct the training of Res-HyperTransformerNet over distributed Internet of Medical Things (IoMT) nodes without the requirement of transferring raw patient data. The embeddings that are created from patient data are then passed on to a PMARL module, where several agents optimize therapy dimensions like medications, diet, physical activity, and mental health interventions independently. To make the clinical support more understandable, the SHAP-based explainability method is used for both predictive and decision-making parts. The framework is tested using two public datasets—the CDC Chronic Disease dataset and the UCI Chronic Kidney Disease Risk Factor dataset. The performance is measured by employing classification metrics (accuracy, precision, recall, F1-score, MCC) as well as reinforcement learning metrics (reward score, convergence steps, episode return) and federated system metrics (communication overhead, convergence rounds, and training time). The experiments indicate that the proposed framework demonstrated improved performance in terms of predictive accuracy and policy convergence speed compared to the baseline deep learning and reinforcement learning models, and at the same time it is more cost-effective when it comes to communication in a federated setting. This means that the proposed method suggests the potential of being a reproducible and open AI framework for adaptive chronic disease therapy management. The combination of ResNet and Transformer blocks, i.e., Federated Res-HyperTransformerNet, achieved strong performance in both datasets, namely CDC Chronic Disease (Dataset 1) and UCI CKD Risk Factor (Dataset 2). The obtained accuracy for Dataset 1 was 98.61% and for Dataset 2, it was 97.75%, under the conducted experimental settings.

chronic disease managementfederated learningprivacy-preserving healthcarechronic disease risk prediction
ArticleOpen (repository)20266citation· Semantic Scholar

Blockchain Consensus Mechanisms and Enhancement Techniques for Federated Learning-Based Intrusion Detection Systems in IoT Smart Homes

Journal of Reliable and Secure Computing · vol. 2 (1) · 1-26

The rapid proliferation of smart home IoT devices has introduced unprecedented cybersecurity vulnerabilities, necessitating scalable and privacy-preserving intrusion detection systems (IDS). Federated Learning (FL) offers a promising decentralized approach by training models locally without sharing raw data, but it remains susceptible to poisoning attacks and relies on a vulnerable central aggregator. This paper presents a novel blockchain-enhanced FL framework tailored for smart home IDS, integrating multiple consensus mechanisms—Proof-of-Stake (PoS), Practical Byzantine Fault Tolerance (PBFT), and Proof-of-Authority (PoA)—for the first time in this context. Our approach uniquely combines differential privacy (DP) and secure aggregation (SA) within a blockchain-managed workflow to mitigate gradient inversion and membership inference attacks while ensuring tamper-resistant, decentralized trust. Experimental evaluation using the N-BaIoT dataset demonstrates that the proposed system achieves up to 88.3% detection accuracy with manageable latency (~200 ms/round) and formal privacy guarantees ($\varepsilon$=1.0 DP). The framework introduces 52.8% system overhead compared to vanilla FL—a reasonable trade-off for enhanced security and privacy. This work establishes a robust, transparent, and scalable security infrastructure for smart homes, effectively addressing the limitations of both centralized and conventional FL-based IDS.

blockchainfederated learningintrusion detection systemshome automation
ArticleOpen access20266citation· Semantic Scholar

Evaluating blockchain-based waste management investments in smart cities using a multi-criteria decision support framework

Scientific Reports · vol. 16 (1) · 3179-3179

With growing urbanization, there are increasing demands on waste management systems that can be performed in an environmentally friendly way as well as efficiently. Current approaches to managing waste often have issues with efficiency, transparency, and engaging with the public. Blockchain technology has been identified as one potential solution to these problems because it offers several benefits including decentralization, security, and transparency. The selection of the best blockchain-based waste management (BBWM) system is very difficult due to the many different evaluation criteria that may conflict with each other. Therefore this research uses a multi-criteria decision making (MCDM) approach using CIMAS (Criteria Importance Assessment), for determining weights based upon subjective input, and LOPCOW (Logarithmic Percentage Change-Driven Objective Weighing), for determining weights based upon objective data within the MCDM framework. To rank alternatives effectively, an Alternative Ranking Order Method Accounting for Two-Step Normalization (AROMAN) technique is applied, ensuring a precise evaluation process. The use of T-Spherical Fuzzy Sets (T-SFS) captures all three (membership, non-membership, hesitation degree) and is used to address the variability that exists when making an expert judgment. Some of the key factors include; Technological Feasibility, Operational Costs, Scalability, Data Security, Regulatory Compliance, Environmental Impact. Based on the evaluation criteria, it appears that the Blockchain Enabled Waste Tracking System is the most appropriate alternative due to its high potential for Transparency, Regulatory Compliance and Fraud Prevention. In addition, this research will provide Policymakers, Urban Planners and Investors with a methodical way of making Data Driven Decisions on BBWM Investments.

smart citiescapital budgetingmulti-criteria decision makingT-spherical fuzzy sets
ArticleOpen access20266citation· Semantic Scholar

Multifunctional Se–Cu bimetallic nanoparticles from marine Bacillus licheniformis : targeting oxidative stress, inflammation, and microbial biofilms

RSC Advances · vol. 16 (8) · 7132-7148

required higher concentrations (84.33% at 75% MBC). These results demonstrated that marine bacterial metabolites produce biocompatible Se-Cu BMNPs with potent antioxidant, anti-inflammatory, antimicrobial, and antibiofilm properties suitable for biomedical applications.

marine bacteriaBacillus licheniformisbacterial metabolitesoxidative stress
ArticleOpen access20265citation· Semantic Scholar

Phytochemical Characterisation, antioxidant, anti-inflammatory, antibacterial, antibiofilm, anticancer properties and therapeutic potentials of Eucalyptus globulus essential oil

Scientific Reports · vol. 16 (1)

The Eucalyptus globulus essential oil (EGEO) is widely recognized for its pharmacological relevance; however, comprehensive evaluation of its phytochemical composition and bioactivities remains limited. In this study, EGEO was extracted from fresh leaves via hydro-distillation and characterized using GC-MS, LCMS, FTIR, and UV-Visible spectroscopy. Qualitative screening confirmed the presence of key secondary metabolites, including triterpenoids, flavonoids, phenols, steroids. Quantitative analysis revealed high levels of total phenolics (65.12 ± 0.01 mg GAE/g) and flavonoids (57.75 ± 0.01 mg QE/g). The oil exhibited concentration-dependent antioxidant activity in the DPPH assay with an IC₅₀ value of 604.01 µl/mL, indicating potent radical-scavenging ability. Anti-inflammatory assessment through protein denaturation and human red blood cell (HRBC) membrane stabilization assays demonstrated moderate inhibitory and cytoprotective effects comparable to standard drugs. EGEO also showed strong antibacterial efficacy against Tannerella forsythia, Prevotella intermedia and Aggregatibacter with inhibition zones of 19-25 mm while showed notable antibiofilm activity against T. forsythia. Cytotoxic evaluation indicated selective action, showing minimal toxicity toward normal L929 fibroblasts and moderate inhibition of B16F10 melanoma cells. Overall, these findings suggest that Eucalyptus globulus essential oil is a rich source of bioactive phytoconstituents with potential therapeutic applications as a natural antioxidant, anti-inflammatory, antibacterial, antibiofilm, and anticancer agent.

Eucalyptus globulusessential oilsphytochemical compositionantioxidant activity